TREATMENT OF RESISTANT ARTERIAL HYPERTENSION
Metaanalyses have demonstrated a linear relationship between level of blood pressure (BP) and risk for cardiovascular events. The prevalence of resistant hypertension in the general population is unknown and vary in the range of 1,9 to 30%. More established approaches, such as low dietary salt and mineralocorticoid receptor blockers are indicated for these patients. New technologies, such as renal denervation and carotid stimulation, may be used in the management of patients with resistant hypertension.
Количество просмотров: 309
Похожие публикации:
ПОСТ-COVID-19-СИНДРОМ: СИМПТОМЫ И ФАКТОРЫ РИСКА
USING THE ROBSON CLASSIFICATION TO ESTIMATE THE CAESAREAN SECTION RATE AND LOOK FOR WAYS TO REDUCE IT
CURRENT PRACTICE IN CARING FOR PEOPLE WITH DEMENTIA
EMBOLIZATION OF THE UTERINE ARTERIES FOR LATE POSTPARTUM HEMORRHAGE DUE TO METROENDOMETRITIS: A CLINICAL CASE
PROBIOTICS AS ADDITIONAL TREATMENT OF RHEUMATOID ARTHRITIS. A REVIEW.